David Heber
Research Subjects
Research Interests
David Heber has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
David A Elashoff
From the Center for Human Nutrition and Division of Clinical Nutrition, the Departments of Medicine and Biomathematics, UCLA School of Medicine, Los Angeles
1 shared publication- George L. Blackburn
Harvard Medical School, Boston, Massachusetts 02215, USA
1 shared publication Ian Yip
From the Center for Human Nutrition and Division of Clinical Nutrition, the Departments of Medicine and Biomathematics, UCLA School of Medicine, Los Angeles
1 shared publicationJudith M Ashley
From the Center for Human Nutrition and Division of Clinical Nutrition, the Departments of Medicine and Biomathematics, UCLA School of Medicine, Los Angeles
1 shared publicationRobert M Elashoff
From the Center for Human Nutrition and Division of Clinical Nutrition, the Departments of Medicine and Biomathematics, UCLA School of Medicine, Los Angeles
1 shared publicationVay Liang W Go
From the Center for Human Nutrition and Division of Clinical Nutrition, the Departments of Medicine and Biomathematics, UCLA School of Medicine, Los Angeles
1 shared publication
Latest Publications
- 1 December 1999
- Published by Oxford University Press (OUP) in The American Journal of Clinical Nutrition
- Vol. 70 (6) , 1114
The Politics of Fat: Food and Nutrition Policy in America
This is an outstanding book that everyone in the nutrition profession should read. It is a timely, concise accounting of the political processes that led to our current food supply, and it suggests that changing the American diet to deal with obesity and related chronic diseases such as heart disease, diabetes, and aging will require retooling a developed bureaucracy and government-industrial complex. Sims points out that there was no conspiracy to change the food supply, but rather there was a well-intentioned effort launched in the 1930s and 1940s to ensure food security. In the 1950s, with the large-scale introduction of cooking oils into the American diet and the widespread availability of choice beef and whole milk, we were ingesting unprecedented amounts of fat.
- 1 December 1999
- Published by Oxford University Press (OUP) in The American Journal of Clinical Nutrition
- Vol. 70 (6) , 1114
The Politics of Fat: Food and Nutrition Policy in America
This is an outstanding book that everyone in the nutrition profession should read. It is a timely, concise accounting of the political processes that led to our current food supply, and it suggests that changing the American diet to deal with obesity and related chronic diseases such as heart disease, diabetes, and aging will require retooling a developed bureaucracy and government-industrial complex. Sims points out that there was no conspiracy to change the food supply, but rather there was a well-intentioned effort launched in the 1930s and 1940s to ensure food security. In the 1950s, with the large-scale introduction of cooking oils into the American diet and the widespread availability of choice beef and whole milk, we were ingesting unprecedented amounts of fat.
- Open Access
- 1 July 1999
- Published by Oxford University Press (OUP) in The American Journal of Clinical Nutrition
- Vol. 70 (1) , 106
Dietary supplement or drug? The case for Cholestin
- 1 July 1999
- Published by Oxford University Press (OUP) in The American Journal of Clinical Nutrition
- Vol. 70 (1) , 106
Open AccessDietary supplement or drug? The case for Cholestin
- Open Access
- 1 February 1999
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 69 (2) , 231-236
Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement
Background: We examined the cholesterol-lowering effects of a proprietary Chinese red-yeast-rice supplement in an American population consuming a diet similar to the American Heart Association Step I diet using a double-blind, placebo-controlled, prospectively randomized 12-wk controlled trial at a university research center. Objective: We evaluated the lipid-lowering effects of this red-yeast-rice dietary supplement in US adults separate from effects of diet alone. Design: Eighty-three healthy subjects (46 men and 37 women aged 34–78 y) with hyperlipidemia [total cholesterol, 5.28–8.74 mmol/L (204–338 mg/dL); LDL cholesterol, 3.31–7.16 mmol/L (128–277 mg/dL); triacylglycerol, 0.62–2.78 mmol/L (55–246 mg/dL); and HDL cholesterol 0.78–2.46 mmol/L (30–95 mg/dL)] who were not being treated with lipid-lowering drugs participated. Subjects were treated with red yeast rice (2.4 g/d) or placebo and instructed to consume a diet providing 30% of energy from fat, Results: Total cholesterol concentrations decreased significantly between baseline and 8 wk in the red-yeast-rice–treated group compared with the placebo-treated group [(x̄ ± SD) 6.57 ± 0.93 mmol/L (254 ± 36 mg/dL) to 5.38 ± 0.80 mmol/L (208 ± 31 mg/dL); P < 0.001]. LDL cholesterol and total triacylglycerol were also reduced with the supplement. HDL cholesterol did not change significantly. Conclusions: Red yeast rice significantly reduces total cholesterol, LDL cholesterol, and total triacylglycerol concentrations compared with placebo and provides a new, novel, food-based approach to lowering cholesterol in the general population.
- 1 February 1999
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 69 (2) , 231-236
Open AccessCholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement
Background: We examined the cholesterol-lowering effects of a proprietary Chinese red-yeast-rice supplement in an American population consuming a diet similar to the American Heart Association Step I diet using a double-blind, placebo-controlled, prospectively randomized 12-wk controlled trial at a university research center. Objective: We evaluated the lipid-lowering effects of this red-yeast-rice dietary supplement in US adults separate from effects of diet alone. Design: Eighty-three healthy subjects (46 men and 37 women aged 34–78 y) with hyperlipidemia [total cholesterol, 5.28–8.74 mmol/L (204–338 mg/dL); LDL cholesterol, 3.31–7.16 mmol/L (128–277 mg/dL); triacylglycerol, 0.62–2.78 mmol/L (55–246 mg/dL); and HDL cholesterol 0.78–2.46 mmol/L (30–95 mg/dL)] who were not being treated with lipid-lowering drugs participated. Subjects were treated with red yeast rice (2.4 g/d) or placebo and instructed to consume a diet providing 30% of energy from fat, Results: Total cholesterol concentrations decreased significantly between baseline and 8 wk in the red-yeast-rice–treated group compared with the placebo-treated group [(x̄ ± SD) 6.57 ± 0.93 mmol/L (254 ± 36 mg/dL) to 5.38 ± 0.80 mmol/L (208 ± 31 mg/dL); P < 0.001]. LDL cholesterol and total triacylglycerol were also reduced with the supplement. HDL cholesterol did not change significantly. Conclusions: Red yeast rice significantly reduces total cholesterol, LDL cholesterol, and total triacylglycerol concentrations compared with placebo and provides a new, novel, food-based approach to lowering cholesterol in the general population.
- 1 February 1999
- Published by Oxford University Press (OUP) in The American Journal of Clinical Nutrition
- Vol. 69 (2) , 344-345
IARC Handbooks of Cancer Prevention: Carotenoids
This is an outstanding book that addresses comprehensively the perennial question asked by the famous carrot-chomping cartoon rabbit, “Eh, what's up Doc ?” In fact, the many different carotenoids found in fruit and vegetables are a fascinating group of compounds with highly significant implications for nutrition at many levels. The book covers the chemical and physical characteristics of carotenoids and the commercial sources of, use and application of, analysis of, and human exposure to carotenoids. In addition, the metabolism of carotenoids, the kinetics and genetic variation of carotenoids in humans and other species, and the preventive and beneficial effects, the carcinogenicity, and other toxic effects of these compounds are also discussed. The book recommends that future research include investigation of better biomarkers, investigation of better animal models, more intervention studies, investigations of food composition, and studies to develop a better understanding of the metabolism of carotenoids and mechanisms of carcinogenesis. The discontinuation of 2 large clinical trials of β-carotene supplementation—the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study and the Carotene and Retinol Efficacy Trial—left many questions unanswered when evidence was found that prospective β-carotene supplementation increased the incidence of lung cancer in heavy smokers. The unexplained effect of β-carotene was made more biologically plausible by the retrospective observation that the increased trend in new cancers could be traced linearly back to early times after exposure. The failure to observe a similar increase in cancer incidence after β-carotene supplementation of healthy men in the Health Professionals Study cohort led to the hypothesis that the smokers' metabolism of carotenoids played a special role in cancer promotion, perhaps by converting antioxidant molecules to prooxidant molecules. These intervention-trial findings were in stark contrast with the epidemiologic findings that higher dietary intakes of β-carotene and higher blood concentrations of β-carotene were associated with a 20–50% decreased risk of lung cancer when persons with the highest concentrations were compared with persons with the lowest concentrations. How should carotenoid intakes from food be ensured or the diet supplemented when many populations clearly do not eat adequate amounts of fruit and vegetables? How do carotenoids interact with each other and with other antioxidants? For those interested in the chemistry, biology, and anticancer properties of carotenoids, this book is an excellent place to begin to explore the epidemiologic, animal science, human metabolism, and clinical intervention trial data in great detail. This book is suitable for postdoctoral fellows, professors, institutional libraries, and those in the government and industry who are interested in this important area of research.
- 1 February 1999
- Published by Oxford University Press (OUP) in The American Journal of Clinical Nutrition
- Vol. 69 (2) , 344-345
IARC Handbooks of Cancer Prevention: Carotenoids
This is an outstanding book that addresses comprehensively the perennial question asked by the famous carrot-chomping cartoon rabbit, “Eh, what's up Doc ?” In fact, the many different carotenoids found in fruit and vegetables are a fascinating group of compounds with highly significant implications for nutrition at many levels. The book covers the chemical and physical characteristics of carotenoids and the commercial sources of, use and application of, analysis of, and human exposure to carotenoids. In addition, the metabolism of carotenoids, the kinetics and genetic variation of carotenoids in humans and other species, and the preventive and beneficial effects, the carcinogenicity, and other toxic effects of these compounds are also discussed. The book recommends that future research include investigation of better biomarkers, investigation of better animal models, more intervention studies, investigations of food composition, and studies to develop a better understanding of the metabolism of carotenoids and mechanisms of carcinogenesis. The discontinuation of 2 large clinical trials of β-carotene supplementation—the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study and the Carotene and Retinol Efficacy Trial—left many questions unanswered when evidence was found that prospective β-carotene supplementation increased the incidence of lung cancer in heavy smokers. The unexplained effect of β-carotene was made more biologically plausible by the retrospective observation that the increased trend in new cancers could be traced linearly back to early times after exposure. The failure to observe a similar increase in cancer incidence after β-carotene supplementation of healthy men in the Health Professionals Study cohort led to the hypothesis that the smokers' metabolism of carotenoids played a special role in cancer promotion, perhaps by converting antioxidant molecules to prooxidant molecules. These intervention-trial findings were in stark contrast with the epidemiologic findings that higher dietary intakes of β-carotene and higher blood concentrations of β-carotene were associated with a 20–50% decreased risk of lung cancer when persons with the highest concentrations were compared with persons with the lowest concentrations. How should carotenoid intakes from food be ensured or the diet supplemented when many populations clearly do not eat adequate amounts of fruit and vegetables? How do carotenoids interact with each other and with other antioxidants? For those interested in the chemistry, biology, and anticancer properties of carotenoids, this book is an excellent place to begin to explore the epidemiologic, animal science, human metabolism, and clinical intervention trial data in great detail. This book is suitable for postdoctoral fellows, professors, institutional libraries, and those in the government and industry who are interested in this important area of research.